FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 324 of 324

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
TVGN Nasdaq Tevogen Inc. 2836
TVRD Nasdaq Tvardi Therapeutics, Inc. 2836
TWST Nasdaq Twist Bioscience Corporation 2836
TXG Nasdaq 10x Genomics, Inc. 2836
UNCY Nasdaq Unicycive Therapeutics, Inc. 2836
URGN Nasdaq UroGen Pharma Ltd. 2836
VALN Nasdaq Valneva SE 2836
VCEL Nasdaq Vericel Corporation 2836
VERA Nasdaq Vera Therapeutics, Inc. 2836
VIVS Nasdaq VivoSim Labs, Inc. 2836
VOR Nasdaq Vor Biopharma Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VSTM Nasdaq Verastem, Inc. 2836
XBIT Nasdaq XBiotech Inc. 2836
XCUR Nasdaq Exicure, Inc. 2836
XENE Nasdaq Xenon Pharmaceuticals Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
XNCR Nasdaq Xencor, Inc. 2836
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2836
YARW Nasdaq Yarrow Bioscience, Inc. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZEOX Over the counter Zeo ScientifiX, Inc. 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
ZTS New York Zoetis Inc. 2836
Results 300 through 324 of 324